Takeda Announces Bold, New Access to Medicines for Sub-Saharan Africa from Nairobi

Takeda Pharmaceutical Company Limited (TSE: 4502) (www.Takeda.com) today announced the launch of a bold, new Access to Medicines (AtM) strategy, aimed at increasing access to its innovative and potentially life-saving medicines for patients with some of the highest unmet medical needs. For decades, the company has provided product, funding and access in many parts of […]http://feedproxy.google.com/~r/Appa-sourceTheAfric...